Our Shareholders
- Focused strategy for Africa with distribution capabilities in key African economies (21Countries).
- Ability to grow in a highly volatile emerging market.
- Innovative and goal driven Healthcare company (Pharma, Disposables, Devices and Ortho):
- Over 9,000 products
- 25 years of experience
- 800 employees
- 35 regulatory pharmacists
- 9 health care production facilities
- US$160 million annual turnover
- Accessing high value dossiers (Proprietary IP) from across the globe building and sustaining long term partnerships
- Click here to visit their website
- Established: 1940
- Type of organisation: Development Finance Institution (DFI)
- Ownership: 100% owned by South African Government
- Total assets: USD 9.6 billion (31 March 2017 – group)
- Total liabilities: USD 3.1 billion (31 March 2017 – group)
- Funding status: Fund operations and growth from investments, pay dividends & income tax
- Credit rating: Baa3 (Moody’s)
- Main business area: Providing funding for big business, entrepreneurs and projects contributing to industrialization
- Geographic activities: South Africa and the rest of Africa
- Stage of investment: Project identification and development, feasibility, commercialization, expansion, modernization
- No. of employees: 839 (March 2017)
- Operational footprint: Head Office in Johannesburg & 20 Regional and Satellite offices
- Click here to visit their website
Afrigen’s Board of Directors
- Dr Moji Mogari – Chairman
- Dr Tadesse Mekonen – Non executive director
- Prof Petro Terblanche – Managing Director
- Dr Caryn Fenner – Technical Director
